Clinical trials
Squamous Cell Carcinoma of Head and Neck trials in Hungary
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 2 |
| 2010 | 3 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 9 |
| Active, not recruiting | 7 |
| Recruiting | 6 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| GlaxoSmithKline | 2 |
| Merus B.V. | 2 |
| Pfizer | 2 |
| AVEO Pharmaceuticals, Inc. | 1 |
| Amgen | 1 |
| Ascendis Pharma A/S | 1 |
| BioNTech SE | 1 |
| Boehringer Ingelheim | 1 |
| CEL-SCI Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Cell Carcinoma of Head and Neck | 34 |
| Head and Neck Neoplasms | 13 |
| Neoplasm Metastasis | 6 |
| Carcinoma, Squamous Cell | 5 |
| Recurrence | 5 |
| Uterine Cervical Neoplasms | 3 |
| Triple Negative Breast Neoplasms | 2 |
| Adenocarcinoma of Lung | 1 |
| Carcinoma | 1 |
| Carcinoma, Hepatocellular | 1 |
Trials
Showing 76 to 34 of 34. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.